Remarkable bone formation following gefitinib for extensive lytic bone metastasis: A report of two cases

Gefitinib inhibits the epidermal growth factor receptor tyrosine kinase and improves survival in patients with non-small-cell lung cancer. We report 2 patients with extensive lytic bony metastasis in the spine and pelvis secondary to advanced pulmonary adenocarcinoma who were treated with gefitinib...

Full description

Saved in:
Bibliographic Details
Main Authors: Bashir, E.S., Kwan, A.K.N., Chan, C.Y.W., Kwan, M.K.
Format: Article
Published: Hong Kong University Press 2016
Subjects:
Online Access:http://eprints.um.edu.my/18476/
http://journals.sagepub.com/doi/10.1177/1602400330
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya